Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
PURE Bioscience (PURE) had Return on Investments of -276.67% for the most recently reported fiscal quarter, ending 2025-07-31.
| Income Statement Financials | |
$0.76M |
|
$-0.33M |
|
$0.30M |
|
$0.47M |
|
$1.10M |
|
$-0.34M |
|
$0.00M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.34M |
|
$-0.34M |
|
111.86M |
|
111.86M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$1.05M |
|
$0.01M |
|
$0.01M |
|
$1.06M |
|
$0.94M |
|
$5.24M |
|
$5.24M |
|
$6.17M |
|
$-5.12M |
|
$-5.12M |
|
$-5.12M |
|
111.89M |
|
| Cash Flow Statement Financials | |
$-2.02M |
|
-- |
|
$2.00M |
|
$0.42M |
|
$0.41M |
|
$-0.01M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
43.63 |
|
-1.02 |
|
61.26% |
|
-43.98% |
|
-43.98% |
|
-- |
|
-43.46% |
|
-43.46% |
|
$-2.02M |
|
-- |
|
-- |
|
-- |
|
0.72 |
|
2.10 |
|
1.61 |
|
55.84 |
|
6.49% |
|
6.49% |
|
-31.38% |
|
|
Return on Investments |
-276.67% |
$-0.05 |
|
$-0.02 |
|
$-0.02 |
|